SNNAQ (Sienna Biopharmaceuticals) Total Current Liabilities: $1.29 Mil (As of Sep. 2019)


What is Sienna Biopharmaceuticals Total Current Liabilities?

Sienna Biopharmaceuticals SNNAQ -99.00% Total Current Liabilities is $1.29 Mil as of Sep. 2019.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Sienna Biopharmaceuticals's total current liabilities for the quarter that ended in Sep. 2019 was $1.29

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Sienna Biopharmaceuticals Total Current Liabilities Related Terms

Sienna Biopharmaceuticals Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Total Current Liabilities Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Total Current Liabilities
1.01 9.88 8.24 24.35

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.81 24.35 22.45 20.81 1.29

Sienna Biopharmaceuticals Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Sienna Biopharmaceuticals's Total Current Liabilities for the fiscal year that ended in Dec. 2018 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=10.636+0
+Other Current Liabilities+Current Deferred Liabilities
=13.713+0
=24.35

Sienna Biopharmaceuticals's Total Current Liabilities for the quarter that ended in Sep. 2019 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.292+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=1.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $1.29 Mil mean?
Sienna Biopharmaceuticals (SNNAQ) has a Total Current Liabilities of $1.29 Mil as of Sep. 2019. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Total Current Liabilities too high?
Sienna Biopharmaceuticals' current Total Current Liabilities is $1.29 Mil.
How does Sienna Biopharmaceuticals' Total Current Liabilities compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Total Current Liabilities of $1.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Total Current Liabilities is $1.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Total Current Liabilities of $1.29 Mil. The current Total Current Liabilities is $1.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Total Current Liabilities is $1.29 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.